Strontium ranelate is a pharmaceutical agent utilized in the treatment of osteoporosis, acting as a bone-forming agent that both stimulates bone formation and inhibits bone resorption. This category contains… Read more
![Chemical structure of 5-[Bis(carboxymethyl)amino]-4-cyano-2-(methoxycarbonyl)-3-thiopheneacetic acid methyl Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2749283-69-8-5-Biscarboxymethylamino-4-cyano-2-methoxycarbonyl-3-thiopheneacetic-acid-methyl-Ester.png&w=3840&q=75)


![Chemical structure of Methyl 5-[bis(2-methoxy-2-oxoethyl)amino]-4-cyano-3-(2-methoxy-2-oxoethyl)-2-thiophenecarboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F674773-13-8-Methyl-5-bis2-methoxy-2-oxoethylamino-4-cyano-3-2-methoxy-2-oxoethyl-2-thiophenecarboxylate.png&w=3840&q=75)


Strontium ranelate is a pharmaceutical agent utilized in the treatment of osteoporosis, acting as a bone-forming agent that both stimulates bone formation and inhibits bone resorption. This category contains a comprehensive selection of high-quality reference standards essential for the rigorous analysis of this medication. Included in this collection are the active pharmaceutical ingredient, along with related pharmacopeial and non-pharmacopeial impurities, synthetic intermediates, and stable isotope-labelled compounds. Pharmaceutical laboratories utilize these materials for critical tasks such as impurity profiling, method validation, and routine quality control testing. Stable isotope-labelled analogues are particularly valuable as internal standards in bioanalytical assays and mass spectrometry-based studies, ensuring accurate quantification and consistent regulatory compliance. These reference materials support the precise monitoring of drug product stability and the characterization of potential degradation products throughout the analytical lifecycle.